Literature DB >> 9218830

IL-5 expressed by CD4+ lymphocytes from Echinococcus multilocularis-infected patients.

L Jenne1, J Kilwinski, W Scheffold, P Kern.   

Abstract

IL-5 is a major factor inducing differentiation of B lymphocytes into immunoglobulin-producing cells as well as a main regulator of eosinophils. Recently, we have shown that peripheral blood mononuclear cells (PBMC) from patients with alveolar echinococcosis (AE) express IL-5 mRNA after stimulation with crude Echinococcus multilocularis (E.m.) antigen. To characterize the observed response in lymphocyte subpopulations, we cultured patients' PBMC in the presence of E.m. crude antigen for 18 h. PBMC were separated from seven patients by fluorescence-activated cell sorting (EPICSorter) into CD4+ and CD8+ subpopulations and from an additional seven patients by magnetic cell sorting (MACS) into CD4+, CD8+ and the CD4+/CD8+ depleted fractions. mRNA was detected by reverse transcriptase-polymerase chain reaction (RT-PCR) for the cytokines IFN-gamma, IL-2, IL-3, IL-4, IL-5, IL-6, IL-10, as well as for beta-actin as control. IL-4 and IFN-gamma expression was positive in all of the patients in the stimulated CD4+ subgroup. IL-5 mRNA expression was detected in eight out of 14 CD4+ samples (58%) and not observed in the other subpopulations, or the unstimulated and healthy controls. Co-expression of other Th2 cytokines in the eight patients expressing IL-5 mRNA was found in five patients for IL-3 and in seven for IL-10. Expression of IL-5 and both Th2 cytokines (IL-3 and IL-10) was only observed in patients judged as critically ill. Out of the six patients who were regarded as cured after radical operation or as stabilized with or without chemotherapy, only two expressed IL-5. Out of those eight patients considered as critically ill, six expressed IL-5 mRNA and five of these co-expressed IL-3 and IL-10. Thus, we conclude that specific antigenic challenge of PBMC from patients with active or previous AE induces an IL-5 response of CD4+ lymphocytes. The expression of Th2-type interleukin mRNA is significantly more frequent in patients clinically judged as progressive. Furthermore, IgE was elevated only in patients regarded as critically ill (six out of eight). In none of the patients were eosinophils elevated. These data support a Th2-type immune response in patients with chronic E. multilocularis infection.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9218830      PMCID: PMC1904720          DOI: 10.1046/j.1365-2249.1997.4031299.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  12 in total

1.  Expression of CD30 mRNA, CD30L mRNA and a variant form of CD30 mRNA in restimulated peripheral blood mononuclear cells (PBMC) of patients with helminthic infections resembling a Th2 disease.

Authors:  J Kilwinski; T Berger; J Mpalaskas; S Reuter; W Flick; P Kern
Journal:  Clin Exp Immunol       Date:  1999-01       Impact factor: 4.330

2.  Distinctive cytokine, chemokine, and antibody responses in Echinococcus multilocularis-infected patients with cured, stable, or progressive disease.

Authors:  Xiangsheng Huang; Beate Grüner; Christian J Lechner; Peter Kern; Peter T Soboslay
Journal:  Med Microbiol Immunol       Date:  2014-02-09       Impact factor: 3.402

3.  Cytokine gene expression in peripheral blood mononuclear cells (PBMC) from patients with pharmacologically treated cystic echinococcosis.

Authors:  R Riganò; E Profumo; B Buttari; A Teggi; A Siracusano
Journal:  Clin Exp Immunol       Date:  1999-10       Impact factor: 4.330

4.  Modulation of cytokine response of pneumonic foals by virulent Rhodococcus equi.

Authors:  S Giguère; B N Wilkie; J F Prescott
Journal:  Infect Immun       Date:  1999-10       Impact factor: 3.441

5.  Resistance/susceptibility to Echinococcus multilocularis infection and cytokine profile in humans. I. Comparison of patients with progressive and abortive lesions.

Authors:  V Godot; S Harraga; I Beurton; M Deschaseaux; E Sarciron; B Gottstein; D A Vuitton
Journal:  Clin Exp Immunol       Date:  2000-09       Impact factor: 4.330

6.  Imunomodulative effect of liposomized muramyltripeptide phosphatidylethanolamine (L-MTP-PE) on mice with alveolar echinococcosis and treated with albendazole.

Authors:  Emília Dvoroznáková; Jarmila Porubcová; Viliam Snábel; Peter Fedorocko
Journal:  Parasitol Res       Date:  2008-06-29       Impact factor: 2.289

Review 7.  Granulocytes in helminth infection -- who is calling the shots?

Authors:  B L Makepeace; C Martin; J D Turner; S Specht
Journal:  Curr Med Chem       Date:  2012       Impact factor: 4.530

8.  Transcriptional profiles of cytokine/chemokine factors of immune cell-homing to the parasitic lesions: a comprehensive one-year course study in the liver of E. multilocularis-infected mice.

Authors:  Junhua Wang; Renyong Lin; Wenbao Zhang; Liang Li; Bruno Gottstein; Oleg Blagosklonov; Guodong Lü; Chuangshan Zhang; Xiaomei Lu; Dominique A Vuitton; Hao Wen
Journal:  PLoS One       Date:  2014-03-17       Impact factor: 3.240

9.  Albendazole increases the inflammatory response and the amount of Em2-positive small particles of Echinococcus multilocularis (spems) in human hepatic alveolar echinococcosis lesions.

Authors:  Franz J Ricken; Juliane Nell; Beate Grüner; Julian Schmidberger; Tanja Kaltenbach; Wolfgang Kratzer; Andreas Hillenbrand; Doris Henne-Bruns; Peter Deplazes; Peter Moller; Peter Kern; Thomas F E Barth
Journal:  PLoS Negl Trop Dis       Date:  2017-05-25

10.  Parasite-specific IL-17-type cytokine responses and soluble IL-17 receptor levels in Alveolar Echinococcosis patients.

Authors:  Christian J Lechner; Beate Grüner; Xiangsheng Huang; Wolfgang H Hoffmann; Peter Kern; Peter T Soboslay
Journal:  Clin Dev Immunol       Date:  2012-08-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.